The contribution of IL-1β signaling in ALS pathogenesis was further exemplified by the findings that gene deletion of either IL-1β or caspase-1 [9] or intracerebroventricular administration of a caspase inhibitor [43] could slow disease progression in SOD1 TG mice. Here, SOD1 is linked to amyotrophic lateral sclerosis.